Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Setrusumab (BPS 804) is a fully humanized monoclonal antibody targeting sclerostin, effectively enhancing bone strength. It is utilized in research on Osteogenesis Imperfecta (OI) and cancer [1].
説明 | Setrusumab (BPS 804) is a fully humanized monoclonal antibody targeting sclerostin, effectively enhancing bone strength. It is utilized in research on Osteogenesis Imperfecta (OI) and cancer [1]. |
In vivo | Setrusumab, administered at a dosage of 100 mg/kg via intravenous injection once weekly for a duration of four weeks, inhibited bone metastasis and muscle weakness induced by breast cancer in mice [1]. |
別名 | BPS 804 |
分子量 | N/A |
CAS No. | 1847394-95-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Setrusumab 1847394-95-9 BPS 804 Inhibitor inhibitor inhibit